Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: A pilot study

Rheumatology (United Kingdom)

Volumn 53, Issue 10, 2014, Pages 1855-1863

  McKay, Neil D ^a,b   Griffiths, Bridget ^a   Di Maria, Costanzo ^a,c   Hedley, Stephen ^a   Murray, Alan ^a,c   Allen, John ^a,c  

^a FREEMAN HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cardiovascular Disease; Photoplethysmography; Raynaud's Phenomenon; Scleroderma; Systemic Sclerosis

Indexed keywords

CORTICOSTEROID; VASODILATOR AGENT;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD FLOW; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FINGER BLOOD FLOW; FINGER ULCER; HUMAN; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOTOELECTRIC PLETHYSMOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; PULSE WAVE; RAYNAUD PHENOMENON; SMOKING; SYSTEMIC SCLEROSIS; WAIST CIRCUMFERENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANKLE BRACHIAL INDEX; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOPLETHYSMOGRAPHY; PILOT PROJECTS; PULSE WAVE ANALYSIS; RAYNAUD DISEASE; REGIONAL BLOOD FLOW; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 84924793048     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu196     Document Type: Article

References (38)

1. Furukawa S, Yasuda S, Amengual O et al. Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study. Ann Rheum Dis 2006;65: 1118–20.
2. Hummers L. Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers. Curr Rheumatol Rep 2006;8:131–7.
3. Sfikakis P, Papamichael C, Stamatelopoulos K et al. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum 2007;56: 1985–93.
4. Szucs G, Timár O, Szekanecz Z et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis—relevance for prevention of vascular complications. Rheumatology 2007;46:759–62.
5. Zhang W, Xu J, Lu Q, Ye S, Liu X. High-resolution magnetic resonance angiography of digital arteries in SSc patients on 3 Tesla: preliminary study. Rheumatology 2011;50:1712–9.
6. Cardillo C, Schinzari F, Melina D et al. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis. Arthritis Rheum 2009;60: 1840–4.
7. Murray A, Moore T, Manning J et al. Non-invasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthritis Rheum 2009;61:1103–11.
8. Allen J. Photoplethysmography and its application in clinical physiological measurement. Physiol Meas 2007; 28:R1–39.
9. Allen J, Murray A. Similarity in bilateral photoplethysmographic peripheral pulse wave characteristics at the ears, thumbs and toes. Physiol Meas 2000;21:369–77.
10. Allen J, Overbeck K, Nath A, Murray A, Stansby G. A prospective comparison of bilateral photoplethysmography versus the ankle-brachial pressure index for detecting and quantifying lower limb peripheral arterial disease. J Vasc Surg 2008;47:794–802.
11. Allen J, Oates C, Lees T, Murray A. Photoplethysmography detection of lower limb peripheral arterial occlusive disease: a comparison of pulse timing, amplitude and shape characteristics. Physiol Meas 2005; 26:811–21.
12. Stevens S, Allen J, Murray A, Jones D, Newton J. Microvascular optical assessment confirms the presence of peripheral autonomic dysfunction in primary biliary cirrhosis. Liver Int 2009;29:1467–72.
13. Allen J, Murray A, Di Maria C, Newton J. Chronic fatigue syndrome and impaired pulse characteristics on orthostasis—a new potential diagnostic biomarker. Physiol Meas 2012;33:231–41.
14. Zheng D, Murray A. Peripheral arterial volume distensibility: significant differences with age and blood pressure measured using an applied external pressure. Physiol Meas 2011;32:499–512.
15. Allen J, Frame JR, Murray A. Microvascular blood flow and skin temperature changes in the fingers following a deep inspiratory gasp. Physiol Meas 2002;23:365–73.
16. Di Maria C. Novel photoplethysmography pulse wave analysis assessments of endothelial dysfunction in patients with coronary artery disease and diabetes mellitus. MSc thesis in Electronic Engineering, University of Bologna, Bologna, Italy, 2010/2011.
17. Masie A. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum —1980;23:581–90.
18. Sacks D, Bakal C, Beatty P et al. Position statement on the use of the ankle–brachial index in the evaluation of patients with peripheral vascular disease: a consensus statement developed by the standards division of the society of cardiovascular and interventional radiology. J Vasc Interv Radiol 2002;13:353.
19. LeRoy E, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988;15:202–5.
20. Medsger T, Steen V. Classification, prognosis. In: Clements P, Furst D, eds. Systemic Sclerosis. Baltimore, MD, USA: Williams & Wilkins, 1996:51–79.
21. Poole J, Steen V. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991;4: 27–31.
22. Clements P, Lachenbruch P, Siebold J et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281–5.
23. Korn J, Mayes M, Matucci Cerinic M et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004;50:3985–93.
24. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY, USA: Wiley, 2000.
25. Anderson K, Di Maria C, Allen J. Novel assessment of microvascular changes in idiopathic restless legs syndrome (Willis-Ekbom disease). J Sleep Res 2013;22: 315–21.
26. Amanzi L, Braschi F, Fiori G et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology 2010; 49:1374–82.
27. LeRoy E, Medsger T Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28: 1573–6.
28. Cozzolino D, Naclerio C, Lengo R et al. Cardiac autonomic dysfunction precedes the development of fibrosis in patients with systemic sclerosis. Rheumatology 2002;41: 586–8.
29. Belch J, McSwiggan S, Lau C. Macrovascular disease in systemic sclerosis: the tip of an iceberg? Rheumatology 2008;47:v16–7.
30. Gunawardena H, Harris N, Carmichael C, McHugh N. Maximum blood flow and microvascular regulatory responses in systemic sclerosis. Rheumatology 2007;46: 1079–82.
31. Sadik H, Moore T, Vail A et al. Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis. Rheumatology 2010;49: 990–6.
32. Herrick A, Roberts C, Tracey A et al. Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. Arthritis Rheum 2009;60:878–82.
33. Avouac J, Fransen J, Walker U et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011;70:476–81.
34. Sebastiani M, Manfredi A, Vukatana G et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012; 71:67–70.
35. Smith V, Decuman S, Sulli A et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis 2012; 71:1636–9.
36. Cutolo M, Smith V. State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology? Rheumatology 2013;52:1933–40.
37. Avouac J, Meune C, Ruiz B et al. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis. Ann Rheum Dis 2012;71:394–9.
38. Koenig M, Joyal F, Fritzler M et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58: 3902–12.